This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
M Batterham , R Garsia & P Greenop (2000) Dietary intake, serum lipids, insulin resistance and body composition in the era of HAART 'Diet FRS Study'. AIDS 14, 1839–1843.
SJ Bell , S Chavali , B Bistrian , CA Connolly , T Utsonomiya & RA Forse (1996) Dietary fish oil and cytokine production during HIV infection. Journal of Parenteral and Enteral Nutrition 20, 43–49.
K Brinkman , H Hofstede , D Burger , J Smeitinik & P Koopmans (1998) Adverse effects of reverse transcriptase inhibitors: mitochondrial toxicity as common pathway. AIDS 12, 1735–1744.
K Brinkman , J Smeitinik , J Romjin & P Reiss (1999) Mitochondrial toxicity induced by nucleoside-analogue reverse transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy. Lancet 354, 1112–1115.
A Carr & D Cooper (2000) Adverse effects of antiretroviral therapy. Lancet 356, 1423–1430.
A Carr , K Samaras , A Thorisdottir , G Kauffman , D Chisholm & D Cooper (1999) Diagnosis, prediction and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study. Lancet 353, 2093–2099.
MW Cloyd (1991) Perturbation of host-cell membrane is a primary mechanism of HIV cytopathology. Virology 181, 500–511.
J Constans , J Pellegrin & E Peuchant (1994) Plasma lipids in HIV-infected patients: a prospective study in 95 patients. European Journal of Clinical Investigation 24, 416–420.
J Constans , E Peuchant & J Pellegrin (1995) Fatty acids and plasma antioxidants in HIV-positive patients: correlation with nutritional and immunological status. Clinical Biochemistry 28, 421–426.
S Endres , R Ghorbani , VE Kelley , K Georgilis , G Lonnemann , JMW van der Meer , JG Cannon , TS Rogers , MS Klempner , PC Weber , EJ Schaeffer , SM Wolff & CA Dinarello (1989) The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumour necrosis factor by mononuclear cells. New England Journal of Medicine 320, 265–271.
C Fernandez-Miranda , F Pulido & JL Carrillo (1998) Lipoprotein alterations in patients with HIV infection: relation with cellular and humoral immune markers. Clinica Chimica Acta 274, 63–70.
JL Gomez-Sirvent , MM Alonso-Socas , FJ Santolaria-Fernandez , CE Gonzalez-Reimers , F Rodriguez-Moreno & H Essardas-Daryanani (1994) Prognostic value of triglyceride levels in early HIV infection. AIDS 8, 1740–1741.
C Grunfeld & K Feingold (1991) The metabolic effects of tumour necrosis factor and other cytokines. Biotherapy 3, 143–158.
C Grunfeld , D Kotler & Shigenaga (1991) Circulating IFN-alpha and hypertriglyceridaemia in AIDS. American Journal of Medicine 90, 154–162.
C Grunfeld , M Pang , W Doerrler , J Shigenaga , P Jensen & K Feingold (1992) Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. Journal of Clinical Endocrinology and Metabolism 74, 1045–1052.
M Hellerstein , C Grunfield , K Wu , M Christiansen , S Kaempfer , C Kletke & C Shackleton (1993) Increased de novo hepatic lipogenesis in HIV infection. Journal of Clinical Endocrinology and Metabolism 76, 559–565.
K Koppel (2000) Serum lipid levels associated with increased risk for cardiovascular disease is associated with highly active antiretroviral therapy (HAART) in HIV-1 infection. International Journal of STD and AIDS 11, 451–455.
S Mallal , M John , C Moore , I James & E McKinnon (2000) Contribution of nucleoside analogue reverse transcriptase inhibitors to subcutaneous fat wasting in patients with HIV infection. AIDS 14, 1309–1316.
P Mercie (2000) Atherogen lipid profile in HIV-1 infected patients with lipodystrophy syndrome. European Journal of Internal Medicine 11, 257–263.
K Mulligan , C Grunfeld , M Hellerstein , R Neese & M Schambelan (1993) Anabolic effects of recombinant human growth hormone in patients with wasting associated with HIV infection. Journal of Clinical Endocrinology and Metabolism 77, 956–962.
E Nunez & N Christeff (1994) Steroid hormone, cytokine, lipid and metabolic disturbances in HIV infection. Baillieres Clinical Endocrinology and Metabolism 8, 803–824.
ER Pacht , P Diaz , T Clanton , J Hart & JE Gaadek (1997) Serum vitamin E decreases in HIV-seropositive subjects over time. Journal of Laboratory and Clinical Medicine 130, 293–296.
J Purnell , A Zambon , R Knopp et al. (1999) Effect of Ritonavir on lipids and post-heparin lipase activities in normal subjects. AIDS 14, 51–57.
R Roubenouff , L Weiss , A McDermott , T Heflin , G Cloutier , M Wood & S Gorbach (1999) A pilot study of exercise training to reduce trunk fat in adults with HIV-associated fat redistribution. AIDS 13, 1373–1375.
C Sappey , P Leclercq , C Coudray , P Faure , M Micoud & A Favier (1994) Vitamin, trace element and peroxide status in HIV seropositive patients: asymptomatic patients present a severe beta-carotene deficiency. Clinica Chimica Acta 230, 35–42.
M Silva , PR Skolnik , SL Gorbach , D Spiegelman , IB Wilson , MG Fernandez-Di Franco & TA Knox (1998) The effect of protease inhibitors on weight and body composition in HIV-infected patients. AIDS 12, 1645–1651.
AK Sullivan , MD Feher , MR Nelson & BG Gazzard (1998) Marked hypertriglyceridaemia associated with ritonavir therapy. AIDS 12, 1393–1395.
MR Taskinen (1995) Insulin resistance and lipoprotein metabolism. Current Opinion in Lipidology 6, 153–160.
MJ Tikkanen , J Ojala & E Helve (1992) Long term use of Lovastatin in different types of hyperlipidaemia. Atherosclerosis 97, S27–S32.
L Turcotte , A Srivastava & J Chiasson (1997) Fasting increases plasma membrane fatty acid-binding protein in red skeletal muscle. Molecular and Cellular Biochemistry 166, 153–158.